基因名 | 疾病 | 靶向药 | 化疗药 | 基因突变 | 临床解释 |
---|---|---|---|---|---|
DICER1 | 腺型卵巢卵黄囊肿瘤,恶性舍托利-莱迪格细胞瘤,卵巢癌,卵巢颗粒细胞瘤,胸膜肺母细胞瘤 | 12 | 18 | ||
DDR2 | 非小细胞肺癌 | 达沙替尼,厄洛替尼, | 7 | 7 | |
DNMT3A | 急性白血病,急性髓系白血病,癌症,骨髓增生异常综合征,T细胞急性淋巴细胞白血病 | 阿特朱单抗,阿替利珠单抗,Decitabine,纳武单抗(纳武利尤单抗),派姆单抗(帕博利珠单抗), | 柔红霉素,伊达比星, | 4 | 37 |
DPYD | 癌症 | 卡培他滨, | 氟尿嘧啶,氟特嗪, | 3 | 3 |
DDIT3 | 黏液样脂肪肉瘤 | NVP-AEW541, | 2 | 3 | |
DROSHA | 癌症,肾威尔姆斯肿瘤 | 2 | 2 | ||
DUX4 | 急性淋巴细胞白血病,小儿B细胞急性淋巴细胞白血病 | 2 | 3 | ||
DCC | 结直肠癌 | 1 | 1 | ||
DEFA1 | 前列腺癌 | 多西他赛, | 1 | 1 | |
DNMT1 | 胃腺癌,卵巢癌 | Decitabine, | 顺铂, | 1 | 2 |
DUSP6 | 癌症 | 曲美替尼, | 1 | 1 | |
DEK | 头颈癌 | 派姆单抗(帕博利珠单抗), | 1 | 1 | |
DLL3 | 小细胞肺癌 | Rova-T, | 1 | 1 | |
DKK1 | 结直肠癌 | L-Folinic Acid, | 氟尿嘧啶,伊立替康,奥沙利铂, | 1 | 1 |
DGKH | 小儿B细胞急性淋巴细胞白血病 | 1 | 1 | ||
DDX41 | 血液癌 | 1 | 1 | ||
DDX43 | 葡萄膜黑色素瘤 | PD0325901,司美替尼,曲美替尼, | 1 | 1 | |
DAXX | 0 | 0 | |||
DHFR | 0 | 0 | |||
DOT1L | 0 | 0 | |||
DCUN1D1 | 0 | 0 | |||
DDB2 | 0 | 0 | |||
DDR1 | 0 | 0 | |||
DDX3X | 0 | 0 | |||
DIS3 | 0 | 0 | |||
DIS3L2 | 0 | 0 | |||
DNAJB1 | 0 | 0 | |||
DNMT3B | 0 | 0 | |||
DPP6 | 0 | 0 | |||
DYNC2H1 | 0 | 0 | |||
DAPK1 | 0 | 0 | |||
DBT | 0 | 0 | |||
DCAF12L1 | 0 | 0 | |||
DCAF12L2 | 0 | 0 | |||
DCAF4L2 | 0 | 0 | |||
DCBLD1 | 0 | 0 | |||
DCK | 0 | 0 | |||
DCLRE1C | 0 | 0 | |||
DDB1 | 0 | 0 | |||
DDX5 | 0 | 0 | |||
DENND1A | 0 | 0 | |||
DEPDC5 | 0 | 0 | |||
DHX35 | 0 | 0 | |||
DHX9 | 0 | 0 | |||
DIAPH1 | 0 | 0 | |||
DIRAS3 | 0 | 0 | |||
DLAT | 0 | 0 | |||
DLC1 | 0 | 0 | |||
DMC1 | 0 | 0 | |||
DMD | 0 | 0 | |||
DNAH1 | 0 | 0 | |||
DNAH6 | 0 | 0 | |||
DNAJC11 | 0 | 0 | |||
DNAJC19 | 0 | 0 | |||
DOCK11 | 0 | 0 | |||
DOCK2 | 0 | 0 | |||
DTX1 | 0 | 0 | |||
DUT | 0 | 0 | |||
DNM2 | 0 | 0 | |||
DNTT | 0 | 0 | |||
DOCK7 | 0 | 0 | |||
DRGX | 0 | 0 | |||
DSCAM | 0 | 0 | |||
DUSP2 | 0 | 0 | |||
DUSP22 | 0 | 0 | |||
DUSP27 | 0 | 0 | |||
DUSP4 | 0 | 0 | |||
DYSF | 0 | 0 |